Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/NovoCure Limited/ 10-K

Annual Report · 10-K

NovoCure Limited

NVCRNASDAQEQUITYCurrent

Annual Report

Filed Feb 26, 2026Accepted Feb 26, 2026, 7:01 AM ESTCIK 1645113Accession 0001645113-26-000017
View company →Permanent SEC source ↗
Share

Company context

Current securities

NVCRNASDAQ · EQUITY · Current

Recent company filings

  1. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 9, 2026
  2. Other EventsSep 1, 2026
  3. 144 filingJul 23, 2026
  4. Results of Operations and Financial ConditionJul 23, 2026
  5. 10-Q filingJul 23, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗